Citation Correction
In the original publication [1], Xue, S.; Ma, M.; Bei, S.; Li, F.; Wu, C.; Li, H.; Hu, Y.; Zhang, X.; Qian, Y.; Qin, Z.; et al. Identification and Validation of the Immune Regulator CXCR4 as a Novel Promising Target for Gastric Cancer. Front. Immunol. 2021, 12, 702615. https://doi.org/10.3389/fimmu.2021.702615 was not cited. The citation has now been inserted in Section 1. Introduction, Paragraph 1, and has replaced the original citation (ref. 4), Han, M.; Lv, S.; Zhang, Y.; Yi, R.; Huang, B.; Fu, H.; Bian, R.; Li, X. The prognosis and clinicopathology of CXCR4 in gastric cancer patients: A meta-analysis. Tumor Biol. 2014, 35, 4589–4597.
The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
Reference
- Cao, Y.; Zhang, S.; Ma, M.; Zhang, Y. Fluorinated PEG-PEI Coated Magnetic Nanoparticles for siRNA Delivery and CXCR4 Knockdown. Nanomaterials 2022, 12, 1692. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).